Skip to main content
Arctic Bioscience logo

Arctic Bioscience — Investor Relations & Filings

Ticker · ABS ISIN · NO0010859580 LEI · 549300Z2HW6I989Q2C78 OL Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2025-08-28 Interim / Quarterly Rep…
Country NO Norway
Listing OL ABS

About Arctic Bioscience

https://arctic-bioscience.com/

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical and nutraceutical products derived from marine membrane lipids. The company utilizes proprietary technology to extract bioactive compounds from herring roe, sourced from sustainable, MSC-certified fisheries. Its nutraceutical product line, marketed under the brand name Romega, consists of high-DHA Omega-3 phospholipid extracts. The pharmaceutical division is focused on developing a novel drug candidate for the treatment of mild-to-moderate psoriasis, aligning with its mission to create therapies for autoimmune disorders. The company's work is supported by extensive research and development to validate the efficacy of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Arctic Bioscience - Stable development with upside potential - Attachment: ABS_Half_year_report_2025.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT' and contains comprehensive financial statements for the first half of 2025 (H1-2025), including an income statement, balance sheet, cash flow statement, and notes to the interim financial statements. It provides a detailed operational review and financial analysis, fitting the definition of an Interim/Quarterly Report. H1 2025
2025-08-28 English
Arctic Bioscience - Stabil utvikling med oppsidepotensial - Attachment: ABS_Half_year_report_2025.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT' and contains comprehensive financial statements for the first half of 2025 (H1-2025), including an income statement, balance sheet, cash flow statement, and notes to the interim financial statements. It provides a detailed operational review and financial analysis, fitting the definition of an Interim/Quarterly Report. H1 2025
2025-08-28 English
Arctic Bioscience - Stable development with upside potential
Earnings Release Classification · 100% confidence The document provides a detailed summary of financial results for the first half of 2025 (H1 2025), including revenue, gross profit, EBITDA, and liquidity figures. It also includes management commentary on business performance, clinical study updates, and future outlook. While it mentions a webcast, the document itself contains the core financial data and management discussion typical of an interim report. It is not merely an announcement of a report, but the report content itself. H1 2025
2025-08-28 English
Arctic Bioscience - Stabil utvikling med oppsidepotensial
Interim / Quarterly Report Classification · 100% confidence The document provides a detailed summary of financial performance for the first half of 2025, including specific revenue figures, EBITDA, margin analysis, and operational updates. It is not merely an announcement of a report, but contains the actual financial data and management commentary for the interim period. Therefore, it is classified as an Interim/Quarterly Report (IR). H1 2025
2025-08-28 Norwegian
Arctic Bioscience - Invitation to presentation of half year 2025 results
Report Publication Announcement Classification · 100% confidence The document is an invitation to a presentation of financial results, not the financial results themselves. It provides details on when the report will be published and invites stakeholders to a webcast. Per the 'Menu vs Meal' rule, since this is an announcement regarding the timing and release of a report, it is classified as a Report Publication Announcement (RPA).
2025-08-21 English
Arctic Bioscience - Invitasjon til presentasjon av halvårsresultat for 2025
Report Publication Announcement Classification · 100% confidence The document is an invitation to a presentation of the half-year results for 2025. It provides the date, time, and link for the webcast, but does not contain the actual financial results or the report itself. According to the 'Menu vs Meal' rule, an announcement regarding the timing and release of a report is classified as a Report Publication Announcement (RPA).
2025-08-21 Norwegian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.